Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study (Q35893543)
Jump to navigation
Jump to search
scientific article published on 5 April 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study |
scientific article published on 5 April 2012 |
Statements
1 reference
Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study (English)
1 reference
Halina Offner
1 reference
Vijayshree Yadav
1 reference
Dennis N Bourdette
1 reference
James D Bowen
1 reference
Sharon G Lynch
1 reference
David Mattson
1 reference
Jana Preiningerova
1 reference
Christopher T Bever
1 reference
Jack Simon
1 reference
Andrew Goldstein
1 reference
Gregory G Burrows
1 reference
Al J Ferro
1 reference
Arthur A Vandenbark
1 reference
1 reference
1 January 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference